These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

277 related items for PubMed ID: 17675901

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Nonalcoholic fatty liver disease: from pathogenesis to patient care.
    Perlemuter G, Bigorgne A, Cassard-Doulcier AM, Naveau S.
    Nat Clin Pract Endocrinol Metab; 2007 Jun; 3(6):458-69. PubMed ID: 17515890
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Nonalcoholic fatty liver disease.
    Hjelkrem MC, Torres DM, Harrison SA.
    Minerva Med; 2008 Dec; 99(6):583-93. PubMed ID: 19034256
    [Abstract] [Full Text] [Related]

  • 8. Nonalcoholic fatty liver disease as a complication of insulin resistance.
    Abdelmalek MF, Diehl AM.
    Med Clin North Am; 2007 Nov; 91(6):1125-49, ix. PubMed ID: 17964913
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Crosstalk between nonalcoholic fatty liver disease and cardiometabolic syndrome.
    Lim S, Taskinen MR, Borén J.
    Obes Rev; 2019 Apr; 20(4):599-611. PubMed ID: 30589487
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Nonalcoholic fatty liver disease and mitochondrial dysfunction.
    Wei Y, Rector RS, Thyfault JP, Ibdah JA.
    World J Gastroenterol; 2008 Jan 14; 14(2):193-9. PubMed ID: 18186554
    [Abstract] [Full Text] [Related]

  • 15. Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals.
    Masuoka HC, Chalasani N.
    Ann N Y Acad Sci; 2013 Apr 14; 1281(1):106-22. PubMed ID: 23363012
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Nonalcoholic fatty liver disease].
    Ko JS.
    Korean J Gastroenterol; 2010 Jul 14; 56(1):6-14. PubMed ID: 20664312
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.